Alicia Buck
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Glioma Diagnosis and Treatment, Phagocytosis and Immune Regulation, Nanowire Synthesis and Applications
Most-Cited Works
- → A prognostic neural epigenetic signature in high-grade glioma(2024)95 cited
- → Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma(2023)70 cited
- → Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis(2017)59 cited
- → High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity(2024)58 cited
- → Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects(2024)41 cited
- → DPI Selectively Inhibits Intracellular NADPH Oxidase Activity in Human Neutrophils(2019)35 cited
- → Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model(2021)31 cited
- → Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker(2024)30 cited
- → In Vivo Transmigrated Human Neutrophils Are Highly Primed for Intracellular Radical Production Induced by Monosodium Urate Crystals(2020)21 cited
- → Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model(2024)20 cited